3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
3
Lymphoma, T-Cell, Cutaneous
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia
1
Kidney Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Bronchogenic
1
Interventions
fludarabine phosphate
23
Cyclophosphamide
23
Peripheral Blood Stem Cell Transplantation
22
Antilymphocyte Serum
18
Busulfan
16
Tacrolimus
15
Mycophenolic Acid
15
Cyclosporine
14
Methotrexate
11
Filgrastim
11
Whole-Body Irradiation
10
Methylprednisolone
9
Melphalan
9
Sirolimus
6
Radiotherapy
6
Psychiatric Rehabilitation
6
Etoposide
6
Cord Blood Stem Cell Transplantation
6
sargramostim
4
Flow Cytometry
4
Early Intervention, Educational
4
Polymerase Chain Reaction
3
Epoetin Alfa
3
Darbepoetin alfa
3
Thiotepa
2
Therapeutics
2
Rituximab
2
Ondansetron
2
Moxifloxacin
2
Morphine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Interleukin-15
×
Dermatologic
×
Clear all
NCT07410676
2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2
Recruiting
83 enrolled